Skip to main content
Log in

Absence of somatotrophs, lactotrophs, and thyrotrophs in the pituitary of two dwarfs with hypothyroidism: Deficiency of pituitary transcription factor-1?

  • Original Article
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Most patients with dwarfism due to growth hormone (GH) deficiency have normal pituitary somatotroph morphology and GH response to GH-releasing hormone (GRH), consistent with decreased GRH synthesis, release, or delivery. Primary pituitary hyposecretion of GH may result from adenohypophysial tissue destruction caused by tumors, such as craniopharyngioma. We report a hitherto undescribed form of primary pituitary dwarfism associated with absence of adenohypophysial GH, prolactin (PRL), and thyrotropin (TSH). Two sisters had dwarfism, hypothyroidism, and hypoglycemia. The first child had craniofacial abnormalities and died at age 11/2 months of fluid overload. The second sibling died at age 4 years of pulmonary congestion. At autopsy, both pituitaries were small and acidophils were conspicuously absent. They contained a normal number of corticotrophs with intense adrenocorticotropin (ACTH) immunoreactivity, and gonadotrophs with normal content of α-subunit and β-subunits of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). No GH, PRL, or β-TSH immunoreactivity was identified. The thyroid glandswere atrophic. Both children had marked pancreatic nesidioblastosis, with an increased number of insulin-containing cells. This clinicopathologic entity appears to represent a familial disorder in which there is defective development of three adenohypophysial cell types: somatotrophs, lactotrophs, and thyrotrophs. A common pituitary transcription factor, Pit-1, has been implicated in the differentiation of these three cell types. The pituitary changes in these two children resemble those described in Snell, Jackson, and Ames dwarf mice, which have recently been shown to be due to abnormalities of the Pit-1 gene. We suggest that this novel human disease is due to deficient or abnormal pituitary transcription factor Pit-1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay M-C, Goossens M. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321:989–995, 1989.

    Article  CAS  Google Scholar 

  2. Amselem S, Duquesnoy P, Goossens M. Molecular basis of Laron dwarfism. Trends Endocrinol Metab 2:35–40, 1991.

    Article  CAS  Google Scholar 

  3. Asa SL, Kovacs K, Horvath E, Losinski NE, Laszlo FA, Domokos I, Halliday WC. Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 48:423–431, 1988.

    Article  CAS  Google Scholar 

  4. Asa SL, Kovacs K, Singer W. Human fetal adenohypophysis: morphologic and functional analysis in vitro. Neuroendocrinology 53:562–572, 1991.

    Article  CAS  Google Scholar 

  5. Bodner M, Karin M. A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 50: 267–275, 1987.

    Article  CAS  Google Scholar 

  6. Borges JLC, Blizzard RM, Evans WS, Furlanetto R, Rogol AD, Kaiser DL, Rivier J, Vale W, Thorner MO. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor. J Clin Endocrinol Metab 59:1–6, 1984.

    Article  CAS  Google Scholar 

  7. Crenshaw EB, Kalla K, Simmons DM, Swanson LW, Rosenfeld MG. Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev 3:959–972, 1989.

    Article  CAS  Google Scholar 

  8. Dollé P, Castrillo J-L, Theill LE, Deerinck T, Ellisman M, Karin M. Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 60: 809–820, 1990.

    Article  Google Scholar 

  9. Frawley LS, Boockfor FR. Mammosomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 12: 337–355, 1991.

    Article  CAS  Google Scholar 

  10. Gerstein HC, Singer W, Asa SL. Clinicopathologic correlations. In: Kovacs K, Asa SL, eds. Functional endocrine pathology. Boston: Blackwell Scientific Publications, 828–861, 1991.

    Google Scholar 

  11. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Nad Acad Sci USA 86:8083–8087, 1989.

    Article  CAS  Google Scholar 

  12. Horvath E, Kovacs K, Scheithauer BW, Randall RV, Laws ER Jr, Thorner MO, Tindall GT, Barrow DL. Pituitary adenomas producing growth hormone, prolactin, and one or more glycoprotein hormones: a histologic, immunohistochemical, and ultrastructural study of four surgically removed tumors. Ultrastruct Pathol 5:171–183, 1983.

    Article  CAS  Google Scholar 

  13. Horvath E, Lloyd RV, Kovacs K. Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 63:511–520, 1990.

    CAS  PubMed  Google Scholar 

  14. Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG. A tissue-specific transcription factor containing a home- odomain specifies a pituitary phenotype. Cell 55:519–529, 1988.

    Article  CAS  Google Scholar 

  15. Lefevre C, Imagawa M, Dana S, Grindlay J, Bodner M, Karin M. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J 6:971–981, 1987.

    Article  CAS  Google Scholar 

  16. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 347:528–533, 1990.

    Article  CAS  Google Scholar 

  17. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L, Nelson C, Elsholtz HP, Rosenfeld MG. A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946–958, 1989.

    Article  CAS  Google Scholar 

  18. Phillips JA III, Hjelle BL, Seeburg PH, Zachmann M. Molecular basis for familial isolated growth hormone deficiency. Proc Nad Acad Sci USA 78:6372–6375, 1981.

    Article  CAS  Google Scholar 

  19. Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. J Clin Endocrinol Metab 59:580–586, 1984.

    Article  CAS  Google Scholar 

  20. Rosenfeld MG. POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev 5:897–907, 1991.

    Article  CAS  Google Scholar 

  21. Schechter J, Kovacs K, Rimoin D. Isolated growth hormone deficiency: immunocyto- chemistry. J Clin Endocrinol Metab 59: 798–800, 1984.

    Article  CAS  Google Scholar 

  22. Vnencak-Jones CL, Phillips JA III, De-Fen W. Use of polymerase chain reaction in detection of growth hormone gene deletions. J Clin Endocrinol Metab 70:1550–1553, 1990.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asa, S.L., Kovacs, K., Halasz, A. et al. Absence of somatotrophs, lactotrophs, and thyrotrophs in the pituitary of two dwarfs with hypothyroidism: Deficiency of pituitary transcription factor-1?. Endocr Pathol 3, 93–98 (1992). https://doi.org/10.1007/BF02921348

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02921348

Keywords

Navigation